Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering

1. Molecular Diagnostics Market & Forecast (By
Application, Technology, Countries, Companies & Clinical
Trials) to 2017: Global Analysis
Renub Research
www.renub.com
Published: April, 2013
Copyright © 2013 Renub Research – All Rights Reserved

2. Global Molecular Diagnostics Market & Future Forecast to 2017 Overview
The global molecular diagnostics market is witnessing a period of profound growth. The growth
is coming from different regions and markets. The next five years will witness significant
developments in molecular diagnostics such as automation, as well as introduction of a wide
range of new products. Molecular Diagnostics involves multiple technologies to identify genetic
variations in individual patients. These technologies include PCR, FISH, hybrid capture,
sequencing and microarrays. The increase in the aging population and incidences of various
chronic diseases are driving the demand of molecular diagnostics world over. The industry is
getting a push from every side and many factors collectively are fuelling the growth in this
industry. Growing with a CAGR of 14.64 percent global molecular diagnostics market is
expected to double its market size in 2017 from the market of 2012.
Molecular Diagnostics Market - Application Segment Analysis
 The infectious disease testing is the leading application in Molecular Diagnostic. It is
likely to hold XXXX% share in 2017.
 Molecular oncology tests have emerged as a second significant rapidly growing market
segment. Genetic Testing and Blood Screening are at the third and fourth spot
respectively in 2012.
 The cardiovascular disease testing and neurological testing are closely competing with
each other to gain the maximum market share.
 Food testing market is expected to inch up to US$ XXXX Million in 2017.
Molecular Diagnostics Market - Technologies Segment Analysis
 Biochips and PCR based test accounts for the largest shares in the molecular diagnostics
technologies segment with XXXX% and XXXX% respectively in 2012.
 Fish & Innovations technology market is at the 3rd
slot.

3. © Renub Research Page 3 of 21
 The PCR related technologies and Non- PCR market is at the 4th
and 5th
position
respectively.
 The biosensor and Molecular Imaging technology are also showing impressive growth.
Molecular Diagnostics Market - Geographical Analysis
 United States molecular diagnostic market is expected to be more than double by 2017
from its current market in 2012.
 Europe stands at the second position in the global molecular diagnostic market.
 China, Japan and India are expected to stand at 3rd
, 4th
and 5th
slot respectively.
 The Mexico molecular diagnostics market is predicted to grow at a CAGR of 17%
between 2012 and 2017.
Molecular Diagnostics Market – Company Wise Analysis
 The Roche molecular diagnostic share is greater than the combined share of Myriad
Genetics and Qiagen which holds the 2nd
and 3rd
position respectively.
 Abbott stands at the 4th
spot and expected to generate sales worth US$ XXXX Million by
the year 2017.
 The Myriad Genetics molecular diagnostic sales were worth US$ XXXX Million in 2012.
Renub Research study titled “Molecular Diagnostics Market & Forecast (By Application,
Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis” provides a
comprehensive assessment of the fast-evolving, high-growth Global Molecular Diagnostics
market. This 157 page report with 81 Figures and 23 Tables studies the Global Molecular
Diagnostics: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical
Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise molecular

4. © Renub Research Page 4 of 21
Diagnostics sales & Forecast 6) Molecular Diagnostic & Personalized Medicines 7) Clinical trials
In Molecular Diagnostics Landscape.
The Report Covers the Following Points
 Global Molecular Diagnostic Market (2010-12) and Forecast (2013 to 2017)
 Global Molecular Diagnostic Application Segment (Infectious Disease Testing, Virology
Testing, HAI Testing, HPV Testing, Critical Care Infectious Testing, Blood Screening,
Genetic Testing, Oncology Testing, Tissue Typing, Cardiovascular Disease Testing,
Neurological Disorders Testing, Food Pathogen Detection Testing & Others) Market
(2010-2012) and Forecast (2013 to 2017)
 Molecular Diagnostic Technology Segment (PCR Based Test, PCR Related Technologies ,
Non-PCR Test, Fish & Innovations Testing, Biochips/Microarrays, Biosensors, Molecular
Imaging, & Other Technologies) Market (2010-2012) and Forecast (2013 to 2017)
 Molecular Diagnostic Geographical Distribution (US, Europe, China, Japan, India, Brazil,
Mexico, South Korea and Rest of World) Market (2010-2012) and Forecast (2013 to 2017)
 Molecular Diagnostic Sales Company Wise Analysis (Roche, Abbott, Myriad Genetics,
Qiagen, BioMérieux and Others ) Market (2010-2012) and Forecast (2013 to 2017)
 Molecular Diagnostic and Road to Personalized medicine
 Molecular Diagnostic Clinical Trial Statements (20 Clinical Trials Studied in the report)
 Driving Forces & Challenges for Global Molecular Diagnostic Market
Data Sources
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Renub Research team of industry experts.

5. © Renub Research Page 5 of 21
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-
printable sources like search engines, News websites, Government Websites, Trade Journals,
White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,
Industry Portals, Industry Associations and access to more than 100 paid databases.

6. © Renub Research Page 6 of 21
About Us
RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long-term experience especially in
international Business-to-Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information Technology
(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,
Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer
Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra-competitive markets.
For more information on us or to view any of our sample work you can mail
us at info@renub.com

7. © Renub Research Page 7 of 21
Published
By
RReennuubb RReesseeaarrcchh
A–116B, Sector–27
Noida – 201301
Phone: +91-120-421-9822, 254-5750 (India)
+1-678-302-0700 (USA)
Fax : +91-120-424-9780
Email: info@renub.com
www.renub.com
© Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies
& Clinical Trials) to 2017: Global Analysis
Renub Research, 2013
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers

8. © Renub Research Page 8 of 21
Table of Contents
1. Executive Summary
2. Molecular Diagnostics Market & Forecast – (2010 – 2017)
3. Molecular Diagnostics Market Share – (2010 – 2017)
3.1 Molecular Diagnostics Market Share & Forecast – Application Wise
3.2 Molecular Diagnostics Market Share & Forecast – Technology Wise
3.3 Molecular Diagnostics Market Share & Forecast – Region Wise
3.4 Molecular Diagnostics Market Share & Forecast – Company Wise
4. Molecular Diagnostics Market (Application Segment) – (2010 – 2017)
4.1 Infectious Disease Testing Market & Forecast
4.1.1 Virology (HIV, HCV, HBV) Testing Market & Forecast
4.1.2 Health – Associated Infections (HAI) Testing Market & Forecast
4.1.3 HPV Testing Market & Forecast
4.1.4 Critical Care Infectious Testing Market & Forecast
4.2 Blood Screening Market & Forecast
4.3 Genetic Testing Market & Forecast
4.4 Oncology Testing Market & Forecast
4.5 Tissue Typing (HLA Testing) Market & Forecast
4.6 Cardiovascular Disease Testing Market & Forecast
4.7 Neurological Disorders Testing Market & Forecast
4.8 Food Pathogen Detection Testing Market & Forecast
4.9 Miscellaneous Testing Market & Forecast
5. Molecular Diagnostics Market (Technologies Segment) – (2010 – 2017)
5.1 PCR Based Test Market & Forecast
5.2 PCR Related Technologies Market & Forecast
5.3 Non-PCR Test Market & Forecast
5.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization) & Forecast
5.5 Biochips/Microarrays Market & Forecast
5.6 Biosensors Market & Forecast

9. © Renub Research Page 9 of 21
5.7 Molecular Imaging Market & Forecast
5.8 Other Technologies Market & Forecast
6. Geographical Distribution – Molecular Diagnostics Market – (2008 – 2017)
6.1 United States Molecular Diagnostics Market & Forecast
6.2 Europe Molecular Diagnostics Market & Forecast
6.3 China Molecular Diagnostics Market & Forecast
6.4 Japan Molecular Diagnostics Market & Forecast
6.5 India Molecular Diagnostics Market & Forecast
6.6 Brazil Molecular Diagnostics Market & Forecast
6.7 Mexico Molecular Diagnostics Market & Forecast
6.8 South Korea Molecular Diagnostics Market & Forecast
6.9 Rest of World Molecular Diagnostics Market & Forecast
7. Molecular Diagnostics Market (Company Wise) – (2010 – 2017)
7.1 Roche Molecular Diagnostics Market & Forecast
7.2 Abbott Molecular Diagnostics Market & Forecast
7.3 Myriad Genetics Molecular Diagnostics Market & Forecast
7.4 Qiagen Molecular Diagnostics Market & Forecast
7.5 BioMérieux Molecular Diagnostics Market & Forecast
7.6 Other Companies Molecular Diagnostics Market & Forecast
8. Molecular Diagnostics and Personalized Medicine
8.1 Road to Personalized Medicine
8.1.1 Historical perspective: HIV & Oncology
8.1.2 Other Applications: Met & Unmet Therapy Areas
8.2 Molecular Diagnostics Technologies
8.2.1 Expression Profiling - RNA & Pharmacogenomics
8.2.2 Expression Profiling - Proteins & Pharmacoproteomics
8.2.3 DNA Sequence Profiling - Pharmacogenetic & SNP Analysis
8.2.4 DNA Sequence Profiling - High-Throughput Sequencing
8.3 Molecular Diagnostics and Personalized Medicine: Value-Assessed Opportunities for Multiple
Stakeholders Values, Needs & Expectations

10. © Renub Research Page 10 of 21
8.4 Regulatory Authorities
8.5 Molecular Diagnostics as Companion Diagnostics: Value-Driven Adoption
8.5.1 Behavioral Impact
8.5.2 Economic Impact (Value-Based vs. Cost-Plus Pricing)
9. Molecular Diagnostics Clinical Trial Statement
9.1 Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
9.2 Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase
(ALK) Translocation
9.3 A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus
9.4 Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
9.5 A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test
9.6 Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin
Lymphoma
9.7 Biopsies of Cancer Patients for Tumor Molecular Characterization
9.8 Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA
Bacteremia
9.9 Collection of Tissue Samples for Cancer Research
9.10 Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
9.11 Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia
9.12 Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy
9.13 Congenital Muscle Disease Study of Patient and Family Reported Medical Information
9.14 Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine Needle
Aspirates
9.15 Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia
(CML) Patients in Chronic Phase
9.16 CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
9.17 Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
9.18 Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
9.19 Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid
Leukemia Chronic Phase Patients

11. © Renub Research Page 11 of 21
9.20 Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
10. Molecular Diagnostics Market – Drivers
10.1 Various Developments in the Molecular Diagnostics Landscape
10.2 Increasing Investment in Genomics & Proteomics Research
10.3 Technological Advances in Molecular Diagnostics
10.4 Increasing Acceptance of the Personalized Medicine
10.5 Growing Molecular Diagnostics for Food Safety
11. Molecular Diagnostics Market – Challenges
11.1 Regulatory Issues
11.2 Various Factors Slowing Growth of Molecular Diagnostics
11.3 Reimbursement Capabilities
11.4 Quality Checkpoints, Awareness & Acceptance

12. © Renub Research Page 12 of 21
List of Figures:
Figure 2-1: Global – Molecular Diagnostics Market (Million US$), 2010 – 2012
Figure 2-2: Global – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 3-1: Global Molecular Diagnostics – Application Wise Market Share (Percent), 2010 – 2012
Figure 3-2: Global Molecular Diagnostics – Forecast for Application Wise Market Share (Percent), 2013 –
2017
Figure 3-3: Global Molecular Diagnostics – Technology Wise Market Share (Percent), 2010 – 2012
Figure 3-4: Global Molecular Diagnostics – Forecast for Technology Wise Market Share (Percent), 2013 –
2017
Figure 3-5: Global Molecular Diagnostics – Region Wise Market Share (Percent), 2010 – 2012
Figure 3-6: Global Molecular Diagnostics – Forecast for Region Wise Market Share (Percent), 2013 – 2017
Figure 4-1: Global – Infectious Disease Testing Market (Million US$), 2010 – 2012
Figure 4-2: Global – Forecast for Infectious Disease Testing Market (Million US$), 2013 – 2017
Figure 4-3: Global – Virology Testing Market (Million US$), 2010 – 2012
Figure 4-4: Global – Forecast for Virology Testing Market (Million US$), 2013 – 2017
Figure 4-5: Global – HAI Testing Market (Million US$), 2010 – 2012
Figure 4-6: Global – Forecast for HAI Testing Market (Million US$), 2013 – 2017
Figure 4-7: Global – HPV Testing Market (Million US$), 2010 – 2012
Figure 4-8: Global – Forecast for HPV Testing Market (Million US$), 2013 – 2017
Figure 4-9: Global – Critical Care Infectious Testing Market (Million US$), 2008 – 2012
Figure 4-10: Global – Forecast for Critical Care Infectious Testing Market (Million US$), 2013 – 2017
Figure 4-11: Global – Blood Screening Market (Million US$), 2007 – 2012
Figure 4-12: Global – Forecast for Blood Screening Market (Million US$), 2013 – 2017
Figure 4-13: Global – Genetic Testing Market (Million US$), 2010 – 2012
Figure 4-14: Global – Forecast for Genetic Testing Market (Million US$), 2013 – 2017
Figure 4-15: Global – Oncology Market (Million US$), 2010 – 2012
Figure 4-16: Global – Forecast for Oncology Market (Million US$), 2013 – 2017
Figure 4-17: Global – Tissue Typing Market (Million US$), 2008 – 2012
Figure 4-18: Global – Forecast for Tissue Typing Market (Million US$), 2013 – 2017
Figure 4-19: Global – Cardiovascular Disease Testing Market (Million US$), 2010 – 2012
Figure 4-20: Global – Forecast for Cardiovascular Disease Testing Market (Million US$), 2013 – 2017
Figure 4-21: Global – Neurological Disorders Testing Market (Million US$), 2010 – 2012
Figure 4-22: Global – Forecast for Neurological Disorders Testing Market (Million US$), 2013 – 2017
Figure 4-23: Global – Food Pathogen Detection Testing Market (Million US$), 2010 – 2012
Figure 4-24: Global – Forecast for Food Pathogen Detection Testing Market (Million US$), 2013 – 2017
Figure 4-25: Global – Miscellaneous Testing Market (Million US$), 2010 – 2012

13. © Renub Research Page 13 of 21
Figure 4-26: Global – Forecast for Miscellaneous Testing Market (Million US$), 2013 – 2017
Figure 5-1: Global – PCR Based Test Market (Million US$), 2010 – 2012
Figure 5-2: Global – Forecast for PCR Based Test Market (Million US$), 2013 – 2017
Figure 5-3: Global – PCR Related Technologies Market (Million US$), 2010 – 2012
Figure 5-4: Global – Forecast for PCR Related Technologies Market (Million US$), 2013 – 2017
Figure 5-5: Global – Non-PCR Test Market (Million US$), 2010 – 2012
Figure 5-6: Global – Forecast for Non-PCR Test Market (Million US$), 2013 – 2017
Figure 5-7: Global – Fish & Innovations Market (Million US$), 2010 – 2012
Figure 5-8: Global – Forecast for Fish & Innovations Market (Million US$), 2013 – 2017
Figure 5-9: Global – Biochips/ Microarrays Market (Million US$), 2010 – 2012
Figure 5-10: Global – Forecast for Biochips/Micrroarrays Market (Million US$), 2013 – 2017
Figure 5-11: Global – Biosensors Market (Million US$), 2010 – 2012
Figure 5-12: Global – Forecast for Biosensors Market (Million US$), 2013 – 2017
Figure 5-13: Global – Molecular Imaging Market (Million US$), 2010 – 2012
Figure 5-14: Global – Forecast for Molecular Imaging Market (Million US$), 2013 – 2017
Figure 5-15: Global – Other Technologies Market (Million US$), 2010 – 2012
Figure 5-16: Global – Forecast for Other Technologies Market (Million US$), 2012 – 2017
Figure 6-1: US – Molecular Diagnostics Market (Million US$), 2002 – 2012
Figure 6-2: US – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 6-3: Europe – Molecular Diagnostics Market (Million US$), 2010 – 2012
Figure 6-4: Europe – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 6-5: China – Molecular Diagnostics Market (Million US$), 2010 – 2012
Figure 6-6: China – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 6-7: Japan – Molecular Diagnostics Market (Million US$), 2010 – 2012
Figure 6-8: Japan – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 6-9: India – Molecular Diagnostics Market (Million US$), 2010 – 2012
Figure 6-10: India – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 6-11: Brazil – Molecular Diagnostics Market (Million US$), 2007 – 2012
Figure 6-12: Brazil – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 6-13: Mexico – Molecular Diagnostics Market (Million US$), 2007 – 2012
Figure 6-14: Mexico – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 6-15: South Korea – Molecular Diagnostics Market (Million US$), 2005 – 2012
Figure 6-16: South Korea – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 6-17: Rest of World – Molecular Diagnostics Market (Million US$), 2010 – 2012
Figure 6-18: Rest of World – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017
Figure 7-1: Roche – Molecular Diagnostics Sales (Million US$), 2008 – 2012
Figure 7-2: Roche – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017

14. © Renub Research Page 14 of 21
Figure 7-3: Abbott – Molecular Diagnostics Sales (Million US$), 2010 – 2012
Figure 7-4: Abbott – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017
Figure 7-5: Myriad Genetics – Molecular Diagnostics Sales (Million US$), 2007 – 2012
Figure 7-6: Myriad Genetics – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017
Figure 7-7: Qiagen – Molecular Diagnostics Sales (Million US$), 2009 – 2012
Figure 7-8: Qiagen – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017
Figure 7-9: BioMérieux – Molecular Diagnostics Sales (Million US$), 2010 – 2012
Figure 7-10: BioMérieux – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017
Figure 7-11: Other Companies – Molecular Diagnostics Sales (Million US$), 2010 – 2012
Figure 7-12: Other Companies – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017
Figure 8-1: A Healthcare ‘Value-Net’

15. © Renub Research Page 15 of 21
List of Tables:
Table 3-1: Global Molecular Diagnostics – Company Wise Market Share (Percent), 2010 – 2012
Table 3-2: Global Molecular Diagnostics – Forecast for Company Wise Market Share (Percent), 2013 –
2017
Table 8-1: Molecular Platforms for Companion Diagnostics
Table 9-1: Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples – Clinical Trials,
2012
Table 9-2: Crizotinib Efficacy in Non-Small Cell Lung Cancer Patients with Anaplastic Lymphoma Kinase
Translocation – Clinical Trials, 2012
Table 9-3: A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus – Clinical
Trials, 2012
Table 9-4: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the
AMLProfiler – Clinical Trials, 2012
Table 9-5: A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test –
Clinical Trials, 2013
Table 9-6: Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin
Lymphoma – Clinical Trials, 2012
Table 9-7: Biopsies of Cancer Patients for Tumor Molecular Characterization – Clinical Trails, 2012
Table 9-8: Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated
MRSA Bacteremia – Clinical Trials, 2013
Table 9-9: Collection of Tissue Samples for Cancer Research – Clinical Trials, 2012
Table 9-10: Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma – Clinical Trials, 2012
Table 9-11: Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia –
Clinical Trials, 2012
Table 9-12: Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy, 2013
Table 9-13: Congenital Muscle Disease Study of Patient and Family Reported Medical Information –
Clinical Trials, 2013
Table 9-14: Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine Needle
Aspirates – Clinical Trials, 2013
Table 9-15: Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia
(CML) Patients in Chronic Phase – Clinical Trials, 2012
Table 9-16: CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib – Clinical Trial, 2013
Table 9-17: Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile –
Clinical Trials, 2013
Table 9-18: Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients –
Clinical Trials, 2012

16. © Renub Research Page 16 of 21
Table 9-19: Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid
Leukemia Chronic Phase Patients – Clinical Trials, 2012
Table 9-20: Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) – Clinical Trials,
2012

17. © Renub Research Page 17 of 21
Related Reports
Point of Care Testing Market and Forecast to 2016: Global Analysis
Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis
Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015)
Asia Medical Tourism Analysis and Forecast to 2015
Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis
Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016
Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
Genetic Testing Market and Forecast - Global Analysis 2010 – 2015
USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)
Global Osteoporosis Market & Drugs Analysis 2010 – 2015
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)
Global Molecular Diagnostics Market & Future Forecast 2010 - 2014
Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs
Analysis
Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 – 2014)
Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities,
Challenges & Future Forecast

18. © Renub Research Page 18 of 21
Our Partial List of Clients
Bain
WAKE Technology Services, Inc.
PSS World Medical
Relypsa
C&K components
Konkuk University
Resonetics
Samsung
SEKISUI MEDICAL CO. LTD.
Plentyoffish Media INC
Arthur D Little Gmbh
Morgan Stanley
Takeda Pharmaceutical Corporation
Hokkai School of Commerce
Ministry of Manpower Singapore
GenOmind, LLC.
Goldman Sachs & Co
NTT Advanced Technology
Tokyo Womens Medical University
The Chemo-Sero-Therapeutic Research
Trade Council of Iceland
Jpmorgan, Ets Trading
GE Healthcare IT
ixia communications
Redbus
Becton Dickinson
Pfizer
Intercell
Sanofi Pasteur
Stanford Burgess
Pequot Capital
DMI
Transgene S.A.
ixia communications
Toyota Tsusho Amercia Inc.
National Health Research Institutes
Abbott Diabetes Care
Corning Incorporated - Life Sciences
L.E.K. Consulting GmbH
Syntiron
MediVas LLC
Credit Suisse
Dune Medical
QIAGEN
Inje University
Mapp Biopharmaceutical
Institute for Information Industry
NorDiag ASA
Rep e Inv Medicas SA de
Innogenetics

19. © Renub Research Page 19 of 21
Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
info@renub.com
Format
Report Title: Molecular Diagnostics Market & Forecast (By Application, Technology, Countries,
Companies & Clinical Trials) to 2017: Global Analysis
Single User
(Email from Publisher)
Hard Copy
(Mail Delivery)
CD – Rom
(Mail Delivery)
Global Site License
(Multiple User License)
US$ 1,400 US$ 1,550 US$ 1,500 US$ 2,200
For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-
countries-companies-clinical-trials-to-2017-global-analysis-114
2) Order by Wire Transfer:
http://renub.com/report/wiretransfer.aspx?id=114&pid=1441
To pay by Wire Transfer, please, fill in your contact details in the form below:

20. © Renub Research Page 20 of 21
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th
Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India
Contact Information
First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:

21. © Renub Research Page 21 of 21
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
A -116B
Sector -27
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780
For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch